Medical Devices APAC

APAC Intravascular Lithotripsy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Intravascular Lithotripsy Market Industry Trends and Forecast to 2034: Segmented by (Application, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $210.1 Mn Placeholder estimate
Estimate 2025 $259.4 Mn 21.8% of the global market
Projected 2034 $1.73 Bn 568.3% Adds $1.47 Bn over 9 forecast years
CAGR 2025–2034 23.5% Faster than 95% of 173 Medical Devices markets here
Key players 5
  • APAC is 21.79% of the global market.
  • Among regions, the largest is North America at $545.0 Mn.
  • Fastest growing: APAC (this report) at 23.5% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.47 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Intravascular Lithotripsy Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $210.1 Mn — —
2025 (base) $259.4 Mn +$49.4 Mn —
2026 (forecast) $320.4 Mn +$61.0 Mn +23.5%
2027 (forecast) $395.7 Mn +$75.3 Mn +52.5%
2028 (forecast) $488.7 Mn +$93.0 Mn +88.4%
2029 (forecast) $603.5 Mn +$114.8 Mn +132.6%
2030 (forecast) $745.4 Mn +$141.8 Mn +187.3%
2031 (forecast) $920.5 Mn +$175.2 Mn +254.8%
2032 (forecast) $1.14 Bn +$216.3 Mn +338.2%
2033 (forecast) $1.40 Bn +$267.2 Mn +441.2%
2034 (forecast) $1.73 Bn +$329.9 Mn +568.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Intravascular Lithotripsy Market Analysis at a glance
Market size, 2025$259.4 Mn placeholder estimate
Forecast, 2034$1.73 Bn placeholder estimate
Growth (CAGR), 2025–203423.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, product and end user (see all)
Key playersShockwave Medical (Johnson & Johnson), Boston Scientific Corporation, Abbott Laboratories, FastWave Medical, Amplitude Vascular (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Intravascular Lithotripsy Market Analysis Executive Summary

Intravascular lithotripsy uses sound waves inside an artery to crack hard calcium, making it easier to place stents.

Key segments of the intravascular Lithotripsy market include application (Coronary, Peripheral and Aortic Access) and product (Catheters and Generators).

Bar chart: Asia Pacific Intravascular Lithotripsy market size, 2024–2034, placeholder estimates. $210.1 Mn in 2024, $259.4 Mn in 2025 and $1.73 Bn in 2034, 23.5% CAGR.
Asia Pacific Intravascular Lithotripsy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Intravascular Lithotripsy Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the intravascular Lithotripsy market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the intravascular Lithotripsy market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the intravascular Lithotripsy market.

Competitive Landscape for Intravascular Lithotripsy Market in APAC

The intravascular Lithotripsy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Intravascular Lithotripsy Market in APAC

Intravascular Lithotripsy in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[11], basic medical insurance (China)⁠[12], the Hospital Authority (Hong Kong)⁠[13], Ayushman Bharat PM-JAY (India)⁠[14], public health insurance (Japan)⁠[15], subsidised public care (Malaysia)⁠[16], Pharmac (New Zealand)⁠[17], PhilHealth (Philippines)⁠[18], MediShield Life (Singapore)⁠[19] and the Universal Coverage Scheme (Thailand)⁠[20].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[12] National Healthcare Security Administration. Checked 14 Nov 2026.

[13] Hospital Authority. Checked 14 Nov 2026.

[14] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[15] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[16] Ministry of Health Malaysia. Checked 14 Nov 2026.

[17] Pharmac. Checked 14 Nov 2026.

[18] PhilHealth. Checked 14 Nov 2026.

[19] CPF Board, MediShield Life. Checked 14 Nov 2026.

[20] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intravascular Lithotripsy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Intravascular Lithotripsy right now, from free public sources.

Patients

Early deaths from long-term diseases, % (WHO)
CountryValueYear
Afghanistan32.82023
Australia8.42023
Bangladesh21.72023
China15.32023
India22.72023
Indonesia21.32023
Japan7.92023
Malaysia19.52023
Myanmar23.22023
Nepal18.22023
New Zealand9.92023
Pakistan24.02023
Philippines22.92023
Singapore8.32023
Thailand14.22023
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Intravascular Lithotripsy in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Intravascular Lithotripsy market in Asia Pacific?
Placeholder estimate: about $259.4 Mn in 2025, rising to about $1.73 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Intravascular Lithotripsy market in Asia Pacific growing?
Placeholder estimate: about 23.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Intravascular Lithotripsy market report cover?
The report splits the market by application (Coronary, Peripheral, Aortic Access), product (Catheters, Generators) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Intravascular Lithotripsy market?
Key players include Shockwave Medical (Johnson & Johnson), Boston Scientific Corporation, Abbott Laboratories, FastWave Medical and Amplitude Vascular.
What is driving the Intravascular Lithotripsy market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the intravascular Lithotripsy market.
How much research is published on Intravascular Lithotripsy?
PubMed lists 854 papers on Intravascular Lithotripsy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on cardiovascular

See the topic